| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.042 | 0.7 |